Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
58.40
+1.20 (2.10%)
At close: Feb 10, 2026

STO:IBT.B Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-65.17-136.91-123.07-65.45-44.99
Other Amortization
0.820.820.820.820.82
Stock-Based Compensation
0.24----
Other Operating Activities
7.04-5.442.07-33-18.85
Change in Accounts Receivable
-2.385.28-9.317.154.34
Change in Other Net Operating Assets
-12.8923.1228.274.693.06
Operating Cash Flow
-72.34-113.13-101.22-85.8-55.62
Other Investing Activities
----0.02-
Investing Cash Flow
----0.02-
Issuance of Common Stock
--101.04--
Other Financing Activities
-2.01-4.521.90.09
Financing Cash Flow
-2.0196.521.90.09
Foreign Exchange Rate Adjustments
7.045.45-2.073318.85
Miscellaneous Cash Flow Adjustments
-14.09-00-0-
Net Cash Flow
-79.38-105.68-6.78-50.91-36.69
Free Cash Flow
-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Margin
--2828325.00%-131453.25%-714958.33%-
Free Cash Flow Per Share
-5.37-8.40-8.19-7.64-4.96
Cash Interest Paid
---0.290.41
Levered Free Cash Flow
-57.33-61.62-64.36-28.66-19.96
Unlevered Free Cash Flow
-57.33-61.62-64.36-28.47-19.71
Change in Working Capital
-15.2728.418.9611.847.4
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.